References
- Ekström P, Carting L, Wettherhus S, Wingren PE, Anker-Hansen O, Lundergårdh G, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous nonsteroidal anti-inflammatory drug therapy. Scand J Gastroenterol 1996; 31: 753–8
- Guglietta A, Hervada T, Nardi RV. Computer-based quantitative morphometric analysis of the dynamic characteristics of indo-methacin and ethanol-induced gastric lesions in the rat. J Pharmacol Meth 1990; 24: 73–8
- Evangelista S, Toja E. Omeprazole accelerates the recovery of gastric mucosal integrity from damage induced by indomethacin in rats. Gastroprotection 1994; 4: 10–4
- Seensalu R, Girma K, Nilsson G. Time course of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats. Eur J Pharmacol 1990; 180: 145–52
- Taha AS, Dudson N, Hawkey CJ, Type PN, Cottrell J, Mann SG, et al. Famotidine for the prevention of gastric and duodenal ulcers caused by nonsteroidal antiinflammatory drugs. N Engl J Med 1996; 334: 1435–9
- Bulbena O, Escolar G, Bravo ML, Navarro C. Experimental reactivation of chronic gastric lesions exposed to different aggressive conditions. Digestion 1991; 50: 43–51